# Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder

> **NCT04963257** · PHASE4 · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 400 (estimated)

## Conditions studied

- OCD

## Interventions

- **DRUG:** sertraline fluvoxamine
- **DRUG:** sertraline

## Key facts

- **NCT ID:** NCT04963257
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2021-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04963257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04963257, "Sertraline Combined With Fluvoxamine in the Treatment of Refractory Obsessive-compulsive Disorder". Retrieved via MORVS 2026-10-15 from https://api.morvs.ai/clinical/NCT04963257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*